In PAP model, several proof-of-principle studies demonstrated the possibility of efficiently correcting CSF2RA-deficiency and restoring human iMph functionality using lentiviral gene transfer. The gene discussed is CSF2RA; the disease is pulmonary alveolar proteinosis.